IBRX vs WDC · rev $51.2M vs P/E 43, rev $12.92B
Immunitybio Inc (IBRX) versus Western Digital Corporation (WDC) — a side-by-side from cached financials, not a winner call.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Western Digital Corporation (WDC) is a computer hardware company listed on NASDAQ.
Latest reported IBRX revenue for 2026-06-30 was $51.2M. Net income was -$230.4M. Revenue was up 15.9% from 2026-03-31 to 2026-06-30. IBRX currently screens at market cap $7.88B.
Latest reported WDC revenue for 2026-07-03 was $12.92B. Net income was $9.42B. Revenue was up 395.9% from 2025-06-27 to 2026-07-03. WDC currently screens at market cap $245.46B and trailing P/E 42.7.
IBRX currently screens at market cap $7.88B. WDC currently screens at market cap $245.46B and trailing P/E 42.7.
Not investment advice. Open the IBRX and WDC stock pages for the full models.
Not investment advice.